Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2005
03/10/2005WO2005021743A1 Primers for nucleic acid amplification and method of examining colon cancer using the same
03/10/2005WO2005021741A2 Diagnostics and therapeutics for diseases associated with kallikrein 11 (klk11)
03/10/2005WO2005021739A1 ANTIBODY AGAINST Nox1 POLYPEPTIDE, METHOD OF DIAGNOSING CANCER WITH THE USE OF Nox1 GENE AND METHOD OF SCREENING CANCER GROWTH INHIBITOR
03/10/2005WO2005021733A2 Methods and compositions for sirna expression
03/10/2005WO2005021731A2 Soluble analyte detection and amplification
03/10/2005WO2005021725A2 Nucleic acid analysis method conducted in small reaction volumes
03/10/2005WO2005021722A2 METHODS AND COMPOSITIONS FOR INHIBITION OF NUCLEAR FACTOR κB
03/10/2005WO2005021719A2 Libraries of recombinant chimeric proteins
03/10/2005WO2005021718A2 Tubulin regulatory elements for use in plants
03/10/2005WO2005021717A2 Oligonucleotide sequestering agents and methods of use
03/10/2005WO2005021712A2 Modified molecular beacons
03/10/2005WO2005021582A2 Methods for the early diagnosis of ovarian cancer
03/10/2005WO2005021563A2 Method and materials for bisulfite conversion of cytosine to uracil
03/10/2005WO2005021044A2 Nanoparticles for delivery of nucleic acids and stable double-stranded rna
03/10/2005WO2005021025A2 MODULATION OF β-CATENIN/TCF ACTIVATED TRANSCRIPTION
03/10/2005WO2005020902A2 Compositions and methods for treating and diagnosing irritable bowel syndrome
03/10/2005WO2005020890A2 Multiplexed molecular beacon assay for detection of pathogens
03/10/2005WO2005020795A2 Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differntial gene expression analysis
03/10/2005WO2005020794A2 Taxane chemosensitivity prediction test
03/10/2005WO2005020785A2 Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
03/10/2005WO2005020784A2 Surrogate cell gene expression signatures for evaluating the physical state of a subject
03/10/2005WO2005012872A2 Liquid crystal based analyte detection
03/10/2005WO2005007823A3 Compositions, kits, and methods for stimulation of homologous recombination
03/10/2005WO2005007815A3 Hairpin-labeled probes and methods of use
03/10/2005WO2005005960A3 High throughput one-hybrid system
03/10/2005WO2005003389A3 In vitro amplification of dna
03/10/2005WO2005003290A3 Methods and devices for determining a cell characteristic, and applications employing same
03/10/2005WO2005003288A3 Diagnostic methods , prognostic methods and pharmaceutical compositions for neurodegenerative diseases like alzheimer’s disease by modulating and investigating genes rgs4 and itpkb, their gene products or fragments and derivatives thereof
03/10/2005WO2005002414A3 Prognosis determination in ewing sarcoma patients by means of genetic profiling
03/10/2005WO2005001129A3 Mobility cassettes
03/10/2005WO2005001115A3 Monitoring gene silencing and annotating gene function in living cells
03/10/2005WO2004112730A3 Method and compositions for treating tumors
03/10/2005WO2004098497A3 Cd4+ human papillomavirus (hpv) epitopes
03/10/2005WO2004094641A3 A novel method of modulating bone-realted activity
03/10/2005WO2004078907A3 Streptococcus pyogenes antigens
03/10/2005WO2004075723A3 Methods for the early diagnosis of ovarian cancer
03/10/2005WO2004074508A3 Method of visualization and quantification of biopolymer molecules immobilized on solid support
03/10/2005WO2004072607A3 High speed assay for glycosyl transferases
03/10/2005WO2004072294A3 Methods and means for nucleic acid sequencing
03/10/2005WO2004072244A9 Polymerase-based protocols for generating chimeric oligonucleotides
03/10/2005WO2004070351A3 Protein fragment complementation assays for high-throughput and high-content screening
03/10/2005WO2004057017A3 Detection of small nucleic acids
03/10/2005WO2004046688A3 Cftr allele detection assays
03/10/2005WO2004046313A3 Methods and compositions for determining methylation profiles
03/10/2005WO2004035753B1 Lmna gene and its involvement in hutchinson-gilford progeria syndrome (hgps) and arteriosclerosis
03/10/2005WO2004016732A3 Astrocyte modulated genes and uses thereof
03/10/2005WO2004013609A8 Use of biomarkers for detecting ovarian cancer
03/10/2005WO2004011079A3 Method of treating disorders by altering ion flux across cell membranes with electric fields
03/10/2005WO2003087834A3 High throughput analysis of recombinant proteins in multi-well plates
03/10/2005WO2003087390A3 Methods for detecting abnormally methylated nucleic acid in heterogeneous biological samples
03/10/2005WO2003085082A3 Nucleic acid reactions using labels with different redox potentials
03/10/2005WO2003079987A3 A non-selective cation channel in neural cells and methods for treating brain swelling
03/10/2005WO2003076570A3 Antigens and their use as diagnostics and vaccines against species of plasmodium
03/10/2005WO2003073990A3 Treatment for asthma or allergies
03/10/2005WO2003073062A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
03/10/2005WO2003072542A3 Interfacial biomaterials
03/10/2005WO2003065008A3 Methods and compositions for identification and therapeutic use of genes involved in vascular and proliferative diseases
03/10/2005WO2003065003A3 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
03/10/2005WO2003062444A3 Array systems and methods
03/10/2005WO2003052425A3 Elisa kit for cyp 2c9 metabolic phenotypes
03/10/2005WO2003040331A3 Prostate cancer genes
03/10/2005WO2003037167A9 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
03/10/2005WO2003010290A3 Novel class ii cytokine receptors and uses thereof
03/10/2005WO2001066772A9 Heparinase iii and uses thereof
03/10/2005US20050055750 Grape plant named RS-9
03/10/2005US20050055734 Prenatal screening
03/10/2005US20050055732 Using allelic variance as diagnostic and prognostic tool in detection and treatment of hyperlipemia
03/10/2005US20050054838 Recovering a calcium-sensitive luminescent protein via gradient elution chromatography
03/10/2005US20050054827 Conotoxin amino acid sequences for use as tool in controlling pain; immunotherapy; mimetics
03/10/2005US20050054825 Osteogenic devices
03/10/2005US20050054823 Genes
03/10/2005US20050054718 4S, 5R, 6R)-5-Acetylamino-4-azido-6-[(S)-4-nitrophenoxycarbonyloxy)-(2-oxo-[1,3]dioxolan-4R-yl)methyl]- 5,6-dihydro-4H-pyran2-carboxylic acid methylester; modified at the carboxyl or hydroxyl or amino functions; orthomyxovirus and paramyxovirus infections; a long lung residency time and high potency
03/10/2005US20050054617 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
03/10/2005US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders
03/10/2005US20050054599 using gene expression to target, detection response to stress
03/10/2005US20050054585 Using saccharide; bone disorders
03/10/2005US20050054575 Peptide agonists of prostate-specific antigen and uses therefor
03/10/2005US20050054573 Kit for detection, monitoring kinase, phosphatase; mixture of peptides; detectable compound; adjustment proteolytic sensitivity
03/10/2005US20050054108 Yeast membrane protein expression system and its application in drug screening
03/10/2005US20050054102 Culturing preferential stem cells and generating pancreatic beta cell tissues via transfection for use in treatment of diabetes, hyperglycemia, and/or impaired glucose tolerance; tissue engineering; regenerative medicine
03/10/2005US20050054050 Green fluorescent protein for use as diagnostic indicator of genic expression in transformed cells; genetic engineering
03/10/2005US20050054046 Evaluating safety, efficacy and biological properties of immunoglobulin receptors; immunotherapeutic agents
03/10/2005US20050054045 Novel G-protein coupled receptor
03/10/2005US20050054041 Kini-3 motor protein and methods for its use
03/10/2005US20050054037 Ferroportin-1 mutant
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050054035 Testicular carnitine transporter and its gene
03/10/2005US20050054034 Polypeptide encoding by a polynucleotide; for detecting diseases; use in diagnosis and in identifying compounds that may be agonists, antagonists as biodrug treating diseases; host cell culturing
03/10/2005US20050054030 Using methylobacterium as bioremediation tool in biodegradation of nitrogen explosive residues; pollution control
03/10/2005US20050054027 Modulators of transmembrane protease serine 6
03/10/2005US20050054025 Stabilized enzymes for detecting and monitoring chemical toxins
03/10/2005US20050054024 Fluorescent assays for protein kinases
03/10/2005US20050054023 development, calibration synthetic peptide models; genetic engineeringincubation mixture of kinase; phosphorylation; measurement; calibration
03/10/2005US20050054022 Identifying compounds which modulate activity of fatty acid transport 5 (FATP5) for use in prevention and treatment of body weight, insulin resistance, dyslipidemia, fatty liver and cardiovascular disorders
03/10/2005US20050054021 Methods of assessing Crohn's disease patient phenotype by I2, OmpC and ASCA serologic response
03/10/2005US20050054018 Using cell cycle checkpoint activation modulators to prevent and treat cell proliferative disorders
03/10/2005US20050054017 Using phosphorylated p21-activated protein kinases (PAK) as diagnostic tool in identifying modulator for prevention and treatment of cell proliferative disorders
03/10/2005US20050054012 Using homeobox repeat sequences as tool in detection and treatment of facial muscular disorders
03/10/2005US20050053998 Methods for identifying and using maintenance genes
03/10/2005US20050053997 Synthesizing polynucleotide sequences based on model generated sequences; bioinformatics; directed evolution of proteins
1 ... 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 ... 3003